The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
Title |
A phase 1 study of dimdazenil to evaluate the pharmacokinetics, food effect and safety in Chinese healthy subjects
|
---|---|
Published in |
Frontiers in Pharmacology, August 2023
|
DOI | 10.3389/fphar.2023.1226014 |
Pubmed ID | |
Authors |
Fei Wang, Jingjing He, Yanling Zhou, Lijun Ye, Bei Li, Zhiyuan Ma, Chunyan Chen, Ruoxi Zhang, Zhaocun Lin, Jinshan Tang, Zhiping Jin, Yu Jiang, Nengming Lin |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 August 2023.
All research outputs
#19,801,320
of 24,332,257 outputs
Outputs from Frontiers in Pharmacology
#9,257
of 18,276 outputs
Outputs of similar age
#175,177
of 247,347 outputs
Outputs of similar age from Frontiers in Pharmacology
#165
of 525 outputs
Altmetric has tracked 24,332,257 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 18,276 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,347 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 525 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.